IGCL — Indogulf Cropsciences Balance Sheet
0.000.00%
- IN₹3.86bn
- IN₹5.57bn
- IN₹7.05bn
Annual balance sheet for Indogulf Cropsciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 48 | 36.9 | 98.9 | 144 | 123 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,623 | 2,057 | 2,453 | 2,657 | 2,906 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 3,232 | 4,214 | 4,530 | 5,597 | 6,755 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 647 | 753 | 653 | 989 | 1,182 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 4,136 | 5,175 | 5,422 | 6,879 | 8,234 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,080 | 2,805 | 2,812 | 3,642 | 3,476 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 2,331 | 3,143 | 3,106 | 4,126 | 3,640 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 1,805 | 2,032 | 2,317 | 2,753 | 4,593 |
| Total Liabilities & Shareholders' Equity | 4,136 | 5,175 | 5,422 | 6,879 | 8,234 |
| Total Common Shares Outstanding |